Mesirow Financial Investment Management, Inc. Artivion, Inc. Transaction History
Mesirow Financial Investment Management, Inc.
- $4.9 Billion
- Q1 2025
A detailed history of Mesirow Financial Investment Management, Inc. transactions in Artivion, Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 10,609 shares of AORT stock, worth $301,826. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,609
Previous 10,609
-0.0%
Holding current value
$301,826
Previous $305,000
14.75%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding AORT
# of Institutions
188Shares Held
38.7MCall Options Held
19.5KPut Options Held
2.5K-
Black Rock Inc. New York, NY6.64MShares$189 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.9MShares$82.6 Million0.09% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$79.5 Million2.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.78MShares$79.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.26MShares$64.3 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.15B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...